Future of radiation therapy for malignant melanoma in an era of newer, more effective biological agents.
about
Sonography of the primary cutaneous melanoma: a reviewHistamine therapeutic efficacy in metastatic melanoma: Role of histamine H4 receptor agonists and opportunity for combination with radiation.Stereotactic radiosurgery for brain metastases from malignant melanomaA combination of high dose rate (10X FFF/2400 MU/min/10 MV X-rays) and total low dose (0.5 Gy) induces a higher rate of apoptosis in melanoma cells in vitro and superior preservation of normal melanocytes.Whole Brain Radiotherapy and RRx-001: Two Partial Responses in Radioresistant Melanoma Brain Metastases from a Phase I/II Clinical Trial: A TITE-CRM Phase I/II Clinical Trial.Targeting DNA repair by coDbait enhances melanoma targeted radionuclide therapyEvaluation of (68)Ga- and (177)Lu-DOTA-PEG4-LLP2A for VLA-4-Targeted PET Imaging and Treatment of Metastatic Melanoma.The influence of postoperative lymph node radiation therapy on overall survival of patients with stage III melanoma, a National Cancer Database analysisProtein and non-protein biomarkers in melanoma: a critical update.Gold nanoparticles as dose-enhancement agent for kilovoltage X-ray therapy of melanoma.Effects of ursolic and oleanolic on SK‑MEL‑2 melanoma cells: In vitro and in vivo assays.Strategies to Improve the Efficacy of Dendritic Cell-Based Immunotherapy for Melanoma.Development of gadolinium based nanoparticles having an affinity towards melanin.In vivo efficacy of melanoma internal radionuclide therapy with a 131I-labelled melanin-targeting heteroarylcarboxamide molecule.Effects of FOXM1 inhibition and ionizing radiation on melanoma cells
P2860
Q30468180-90620FC3-B52C-47B1-9264-92C912331AFAQ33688711-B1BDDF8A-4361-4DC2-A067-C03FC452D9ECQ36007729-8409D063-190D-4D56-B7DB-859B9CF9D75FQ36028539-CE220580-613C-44BC-91F9-88CD1E1C3F23Q36804495-BDDB43D8-1E94-4EAD-B6D8-8BD59FC61E30Q37022343-2DD1C9B5-8AD5-4D56-8CC3-94D54414DA96Q37515861-1D827F89-39D1-4BDA-BE81-3A11EE7BDD67Q37729387-B372DB23-B09F-417B-85B7-FD1867D75205Q38050990-E1694FC6-17D5-4633-8BE8-86C98000355FQ38723180-FF93F5DF-9553-4CF4-973E-5B52C6770B6EQ45665487-BA2799BE-801E-428C-B4D1-9E65132A2542Q47135720-288644CB-BC64-4C58-93FE-E4391135E908Q51534151-EBF9A009-45A2-492A-856C-D99DF14C37F3Q53120428-C53D8A60-A2C9-4C4F-A885-9A449BD9E482Q58572024-AF8B845C-95FE-4A31-AC35-432577046C93
P2860
Future of radiation therapy for malignant melanoma in an era of newer, more effective biological agents.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Future of radiation therapy fo ...... e effective biological agents.
@ast
Future of radiation therapy fo ...... e effective biological agents.
@en
type
label
Future of radiation therapy fo ...... e effective biological agents.
@ast
Future of radiation therapy fo ...... e effective biological agents.
@en
prefLabel
Future of radiation therapy fo ...... e effective biological agents.
@ast
Future of radiation therapy fo ...... e effective biological agents.
@en
P2860
P356
P1476
Future of radiation therapy fo ...... e effective biological agents.
@en
P2093
Niloufer Khan
Roger Macklis
P2860
P304
P356
10.2147/OTT.S20257
P407
P577
2011-08-09T00:00:00Z